RSV is a common respiratory virus but can cause serious complications with high mortality and morbidity among older adults. Likewise, pediatric populations can also be disproportionately at risk. In this session, immunization colleagues discuss the new vaccines and approaches to protecting patients against RSV. As with all ‘Beyond the Classroom’ discussions, participants will be able to interact directly with the panelists in real time.